Eyenovia Analyst Ratings
Eyenovia Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/17/2023 | 459.44% | Brookline Capital | → $8 | Initiates Coverage On | → Buy |
08/18/2023 | 739.16% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
08/11/2023 | 739.16% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
05/12/2023 | 739.16% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
04/19/2023 | 739.16% | HC Wainwright & Co. | → $12 | Reiterates | → Buy |
04/03/2023 | 739.16% | HC Wainwright & Co. | → $12 | Reiterates | → Buy |
10/05/2022 | 739.16% | HC Wainwright & Co. | → $12 | Initiates Coverage On | → Buy |
04/01/2021 | 459.44% | HC Wainwright & Co. | $6 → $8 | Maintains | Buy |
10/23/2020 | 319.58% | HC Wainwright & Co. | $7 → $6 | Maintains | Buy |
10/14/2020 | 669.23% | Roth Capital | $14 → $11 | Maintains | Buy |
08/13/2020 | 389.51% | HC Wainwright & Co. | $6 → $7 | Maintains | Buy |
03/26/2020 | 319.58% | HC Wainwright & Co. | $10 → $6 | Reiterates | Buy → Buy |
02/03/2020 | — | Oppenheimer | Downgrades | Outperform → Perform | |
04/25/2019 | 529.37% | Oppenheimer | → $9 | Initiates Coverage On | → Outperform |
日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
---|---|---|---|---|---|
10/17/2023 | 459.44% | 布魯克林資本 | →$8 | 開始承保 | →購買 |
2023年08月18日 | 739.16% | HC Wainwright公司 | →$12 | 重申 | 購買→購買 |
2023年08月11日 | 739.16% | HC Wainwright公司 | →$12 | 重申 | 購買→購買 |
2023年05月12日 | 739.16% | HC Wainwright公司 | →$12 | 重申 | 購買→購買 |
04/19/2023 | 739.16% | HC Wainwright公司 | →$12 | 重申 | →購買 |
04/03/2023 | 739.16% | HC Wainwright公司 | →$12 | 重申 | →購買 |
10/05/2022 | 739.16% | HC Wainwright公司 | →$12 | 開始承保 | →購買 |
04/01/2021 | 459.44% | HC Wainwright公司 | $6→$8 | 維護 | 買 |
10/23/2020 | 319.58% | HC Wainwright公司 | $7→$6 | 維護 | 買 |
10/14/2020 | 669.23% | 羅斯資本 | $14→$11 | 維護 | 買 |
2020年08月13日 | 389.51% | HC Wainwright公司 | $6→$7 | 維護 | 買 |
03/26/2020 | 319.58% | HC Wainwright公司 | $10→$6 | 重申 | 購買→購買 |
02/03/2020 | - | 奧本海默 | 評級下調 | 超越→表現 | |
2019年04月25日 | 529.37% | 奧本海默 | →$9 | 開始承保 | →跑贏大盤 |
What is the target price for Eyenovia (EYEN)?
Eyenovia(Eyen)的目標價是多少?
The latest price target for Eyenovia (NASDAQ: EYEN) was reported by Brookline Capital on October 17, 2023. The analyst firm set a price target for $8.00 expecting EYEN to rise to within 12 months (a possible 459.44% upside). 6 analyst firms have reported ratings in the last year.
Brookline Capital於2023年10月17日報道了Eyenovia(納斯達克:Eyen)的最新目標價。這家分析公司將目標價定為8美元,預計日元將在12個月內上漲(可能上漲459.44%)。6家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Eyenovia (EYEN)?
分析師對Eyenovia(Eyen)的最新評級是多少?
The latest analyst rating for Eyenovia (NASDAQ: EYEN) was provided by Brookline Capital, and Eyenovia initiated their buy rating.
布魯克林資本對Eyenovia(納斯達克:Eyen)的最新分析師評級是由Eyenovia發起的買入評級。
When is the next analyst rating going to be posted or updated for Eyenovia (EYEN)?
Eyenovia(Eyen)的下一次分析師評級將於何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Eyenovia, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Eyenovia was filed on October 17, 2023 so you should expect the next rating to be made available sometime around October 17, 2024.
分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與Eyenovia的高管和客戶交談,以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Eyenovia的上一次評級是在2023年10月17日提交的,所以你應該預計下一次評級將在2024年10月17日左右的某個時候公佈。
Is the Analyst Rating Eyenovia (EYEN) correct?
分析師對Eyenovia(Eyen)的評級正確嗎?
While ratings are subjective and will change, the latest Eyenovia (EYEN) rating was a initiated with a price target of $0.00 to $8.00. The current price Eyenovia (EYEN) is trading at is $1.43, which is within the analyst's predicted range.
雖然評級是主觀的,並將發生變化,但最新的Eyenovia(Eyen)評級是以0.00美元至8.00美元的目標價啟動的。目前Eyenovia(Eyen)的交易價格為1.43美元,在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。